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Abstract: Policy dialogs are deliberative dialogue that gather policy makers and relevant stakeholders
from across disciplines to discuss a topic of mutual interest. They typically serve as a single element
in a broader policymaking cycle, either informing the content of new policy or forming a component
of policy evaluation and review. In the joint action CHRODIS PLUS, national policy dialogs were
conducted in fourteen EU Member States. The aim of the dialogs was to identify new policies or
changes to existing policies and legislation that are capable of tackling major risk factors for chronic
disease, to strengthen health promotion and prevention programs and to ensure health systems are
equipped to respond to priority issues within the chronic diseases field. In this paper, we present the
CHRODIS PLUS policy dialog methodology, as well as results and lessons learnt from three national
policy dialogs held in Ireland, Portugal and Spain. After discussion of the results, we conclude that
the CHRODIS PLUS methodology is an effective mechanism to provoke deliberative discussion
around chronic disease prevention and management in different countries. However, it is essential to
ensure adequate human and financial resources—as well as political commitment—to accomplish
objectives set out during the policy dialogs. We argue that priority-setting across sectors can improve
the resilience of health systems and opportunities for investment in Health in All Policies (HiAP),
both at European Union and Member State levels.
Keywords: policy; chronic diseases; deliberative dialog; complexity; health systems; public health;
stakeholder engagement; policymaking; innovation; prevention; health promotion; health in
all policies
1. Introduction
1.1. The Challenge of Chronic Diseases in Europe and the Joint Action CHRODIS PLUS
National health systems require further resources and capacity if they are to meet the growing
challenge of chronic diseases. Eighty-five percent of all-cause deaths in the European Union (EU) are
due to chronic diseases [1]. In the EU in 2016, two-thirds of premature deaths of people under 75
were avoidable, meaning that 1.2 million of 1.7 million deaths could have been averted by reasonable
means [2]. Of these, 741,000 deaths could have been prevented through effective public health and
primary prevention interventions and 422,000 deaths could have been avoided through timely and
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effective healthcare interventions. While 80% of total healthcare costs are spent on managing chronic
disease, with further associated expenses for social protection systems, an average of only 3% of
national health budgets are allocated to preventative care/collective measures [3]. Reducing the
incidence of chronic diseases is key to reduce the burden on health systems.
As a response to this challenge, the joint action (JA) CHRODIS PLUS was funded by the European
Commission from 2017–2020 [4]. A joint action is a collaborative action among countries participating
in the EU Health Program to “develop, share, refine, test tools, methods and approaches to specific
issues and engage in capacity building in key areas of interest” [5]. The specific goal of CHRODIS
PLUS is to support—using cross-national initiatives identified in the preceding CHRODIS joint action
(2014–2017)—to reduce the burden of chronic disease while assuring health systems sustainability and
responsiveness [6].
CHRODIS PLUS supports Member States in the implementation of new or innovative policies
and practices for health promotion and disease prevention, management of chronic diseases and
multimorbidity, as well as addressing social aspects such as employment and chronic diseases [4].
As part of this effort, national policy dialogs were held in fourteen EU Member States. The policy
dialogs aimed to enhance the development of national policy responses on the prevention of chronic
disease and served as a tool to strengthen the development of policies and strategies related to
health promotion, disease prevention and innovative management of chronic diseases (Annex I).
Policy developments were not prescribed from the outset but could include enhanced implementation
of existing policy commitments or a change of focus or priority, as well as the emergence of new
innovative policy options. Policy dialogs sought to provide a “safe space” for participants from
different disciplinary or departmental backgrounds to discuss the challenges and opportunities for
intersectoral cooperation in chronic disease prevention and management.
The aim of this paper is to explore the ways in which the CHRODIS PLUS policy dialogs were
perceived and evaluated, planned and managed in the unique context of a European joint action and
specifically in three national settings. It aims to establish what lessons can be drawn for the future
use of policy dialogs as a deliberative dialog and upstream policymaking tool in health. Furthermore,
this paper aims to contribute to the evolving literature on the utility of policy dialogs and their potential
for enhancing country-level responses to chronic diseases.
1.2. Policy Dialogs and the CHRODIS PLUS National Policy Dialogs
A policy dialog is a type of deliberative dialog. Although policy dialogs play a crucial role in the
policymaking process, they are often understood and applied in different ways and by different actors.
The European Observatory on Health Systems and Policies, for example, defines a policy dialog as
“an event where dialog takes place around “a policy question . . . on which . . . key documents and
international experts . . . [are brought together] to present recent evidence, as well as relevant case
studies from countries that have faced a similar question”” [7]. Policy dialogs are also described as
“component [s] of the policy and decision-making process . . . intended to contribute to informing,
developing or implementing a policy change following a round of evidence-based discussions,
workshops, and consultations on a particular subject” [8]. Important elements inherent in policy
dialogs include a certain amount of existing or potential alignment of “beliefs, values, interests and
goals/strategies of elected officials and social interest groups” [9], the use of multidisciplinary teams
to translate evidence into policy and a measure of transparency and accountability to ensure broad
support [10]. Naturally, it cannot be presumed that a single policy dialog can change legislation or
bring about a new strategy in a vacuum. Nevertheless, a well-organized dialog can contribute to such
objectives. The policy dialog model has demonstrated to be particularly useful in times of transition to
help study past achievements and explore strategic options for further health system reform [11].
The existing literature on policy dialogs has highlighted the value of studying the impact of
collective decisions, actions, processes and goals on governmental and organizational decision-making
and the use of evidence in policy [12–14]. Policy and governance literature [15] describes a policymaking
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cycle that includes: (1) defining problems [16] and agenda setting [17], (2) policy formulation,
(3) decision-making, (4) implementation and (5) evaluation [18], which may or may not occur
sequentially. Each stage is subject to complex interacting elements that can influence policy progression
and similarly influence the effect of any given policy dialog [19]. Despite the growing literature that
advocates for the value and implementation of deliberative dialogs such as policy dialogs, there has
been insufficient evaluation of their influence on the policymaking process [20]. The prevention and
management of chronic disease are complex policy issues and require cross-sectoral action addressing
upstream as well as downstream determinants of disease [21]. Policy dialogs provide the opportunity to
discuss not just the role of health policy, but also the potential for better coordination across government
and stakeholders in line with a Health in All Policies (HiAP) approach [22].
The CHRODIS PLUS national policy dialogs were designed to either start policy processes or
support ongoing policy developments. The overall expectation of the dialogs was to foster agreement on
collaborative actions to respond to a defined policy issue and act as a catalyst for progress to implement
those actions. The specific objectives varied across Member States and topics, including: (a) initiating
or contributing to legislative change intended to help prevent or reduce the burden of chronic diseases,
(b) establishing governance mechanisms for institutional/cross-sectoral collaboration/consultation,
(c) reaching consensus on tangible actions that will address the identified problem and assigning
responsible actors, (d) increasing political will and engagement towards new or adapted policies.
In CHRODIS PLUS, “deliberative” policy dialogs were used because they are a critical tool to aid
the development of responsive, effective, sustainable and evidence-informed policy [23]. They gave
participants a single medium through which they could address multiple influences on the policy
process, such as the engagement of key stakeholders, the latest research evidence and existing policy
and practice [19]. It is important to note, however, that feedback from participants in the CHRODIS
PLUS national policy dialogs indicated that their efficacy as a tool would have been enhanced had
the joint action envisioned providing sustained financial support to the dialog process, as well as a
framework for monitoring implementation of related action plans over the short-, mid- and long-term.
Current literature also supports the importance of sufficient financial commitment for policy dialog
processes [24].
1.3. Outline of the Paper
This paper explores the practicalities of the CHRODIS PLUS national policy dialog planning and
implementation processes and reviews the results of three dialogs in more detail.
The outline of this paper is as follows:
• In the Methods section, we set out the CHRODIS PLUS policy dialog methodology (see Supplementary
Table S1 for the participating Member States, dialog topics and national organizers).
• In the Results section, we present three case studies: the national policy dialogs organized in
Ireland, Portugal and Spain. These dialogs were selected because they chose major modifiable risk
factors for chronic disease as their primary themes, including tobacco, overweight and obesity and
environmental conditions. They were also all working on the basis of existing policy or proposed
legislation, which they wished to either make more effective or formally pass into law. The dialogs
were held on: (1) reducing socioeconomic inequalities in smoking as part of the application of
the Tobacco-Free Ireland policy and the Healthy Ireland Framework (Ireland), (2) reducing the
growing rate of obesity and chronic disease with a particular focus on children and young people
via a proposed law regulating food marketing and advertising (Portugal) and (3) alternatives for
the effective implementation of health impact assessment as part of the application of the Spanish
Public Health Act (Spain). In addition, these were among the dialogs with the highest response
rates to the participant feedback questionnaire (see Section 2.6 and Table 1), giving us greater
insights into perceived strengths and weaknesses of the respective dialogs.
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• In the Discussion section, we build on the results and discuss the value of policy dialogs as a tool for
enhancing policymaking, focusing on building coalitions, taking a HiAP approach, strengthening
EU added value of national policymaking and standardizing policymaking processes.
• Finally, we present our conclusions from the national policy dialogs and suggestions for
further research.
Table 1. Summary of the feedback questionnaire respondents from ten of fourteen national policy
dialogs of CHRODIS PLUS.
Country Participants Respondents Response Rate
Croatia 15 7 47%
Hungary 12 4 33%
Ireland 7 4 57%
Italy 17 7 41%
Malta 10 8 80%
Poland 19 8 42%
Portugal 17 11 65%
Slovakia 11 3 27%
Slovenia 16 7 44%
Spain 18 11 61%
2. Methods
2.1. Organizing a Policy Dialog
The key features of a deliberative dialog are: (1) the meeting environment (enabling or inhibiting),
(2) the mix of participants (expertise, experience, interests, capacity) and (3) the role of evidence [25].
Deliberative approaches like those used in policy dialogs foster structured conversations that
promote listening as much as speaking, in order to feed into an informed and reasoned agreement.
Participants are encouraged to explore the values that may underlie opposing views and weigh
reasons for and against different policy options, with the aim to determine mutually agreed action [26].
These approaches enable participants to explore diverse views, build relationships of trust and improve
their understanding of the working context of other key stakeholders. They also connect research to
personal/lived experience, including patients’ voices and help participants to develop agency to take
action within their own spheres [27].
The CHRODIS PLUS guide for the national policy dialogs was developed to incorporate key
features of deliberative dialogs and to explain essential enabling requirements of the dialogs [28].
These key features include defining roles and responsibilities, preparing responses to the CHRODIS
PLUS questionnaire (part of the CHRODIS PLUS guide for national policy dialogs), preparing the
meeting agenda and inviting participants, reporting the dialog and preparing the action plan and
evaluating the dialog’s implementation (through the use of participant feedback questionnaires).
Each step is further described below.
If the National Policy Dialogs needed ethical approval, the national legislation was strictly followed.
The subjects gave their informed consent for inclusion before they participated in the National Policy
Dialogs. If the ethical approval was needed, the National Policy Dialogs were conducted in accordance
with the Declaration of Helsinki and the protocol was approved by the respective Ethics Committee.
Grant Agreement: 761307—CHRODIS-PLUS: Implementing good practices for chronic diseases
(CHRODIS-PLUS). The joint action CHRODIS-PLUS is funded by the Health Program 2014–2020 of
the European Union.
2.2. Assignment of Predefined Roles and Responsibilities
The three key roles in the CHRODIS PLUS national policy dialogs were:
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a National organizer
The national organizer had the primary responsibility for the overall design and execution of the
dialog, including selection of the topic, invitation of participants and compiling the final report and
action plan. They also played an important role in managing the expectations of the participants by
communicating the aims of the dialog, providing background material and questions in advance of the
discussion and clarifying the rules of the dialog.
b Moderator
It was the responsibility of the national organizer to arrange for professional (external or internal)
moderation. The role of the moderator was to trigger, maintain and conclude the discussion while
directing the participants to agree on tangible actions. Ideally, the moderator was an external person to
the national organizer with both thorough knowledge of the dialog topic and experience in moderation
and facilitation. Knowledge of the topic allowed the moderator to direct the conversation, as needed,
towards a more in-depth examination of barriers, facilitators and potential avenues for addressing the
identified problem.
c Rapporteur
The role of the rapporteur was to accurately record and report the discussion of the policy
dialog. The rapporteur was tasked with clearly identifying the tangible actions that will address the
identified problem. The use of Chatham House Rules, which allow for disclosure of information
without identifying the source of the information (e.g., identity and affiliation of the speaker(s) and
other participants), helped establish an environment that allowed a full and frank discussion of the
identified problem [29].
2.3. Questionnaire Planning
A purpose-built questionnaire (Supplementary Table S2) was completed by each national organizer.
There were several essential components for participants to consider:
• Clearly defining the objectives of the dialog. This goes hand-in-hand with a clear vision of what
outcomes and results would be expected.
• Conducting a comprehensive context analysis as part of a problem definition to select main points
for discussion.
• Conducting an effective stakeholder analysis (as a part of collecting evidence-based background
information) to select policy dialog participants. As further described below, participation was
invitation-only and limited to build trust and ensure more frank and open flow of conversation.
• Identifying a moderator who would be able to provide effective moderation and facilitation.
This was key to having meaningful and comprehensive discussions.
• Defining tangible and feasible actions or steps to achieve the expected results of the dialog.
This was done through an action plan (further detailed below). Actions may or may not occur
during the period of the joint action.
• Ensuring follow-up and the will to implement. The policy dialogs were not intended to be
“one-off” activities, but rather the initiation or continuation of a broader policymaking process.
• Describing the potential added value of their actions to wider European efforts to prevent and/or
manage chronic disease.
The national policy dialogs were conceptualized and planned on the basis of the questionnaire.
The topic, objectives and desired outcomes for each national dialog were reviewed and refined in
iterative and close collaboration with the CHRODIS PLUS task leaders. Each topic was context-specific
to the Member State, but there was some overlap across different countries.
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2.4. Meeting Agenda and Participation
It is important to highlight that the national policy dialogs were not intended as dissemination
events. The main goal was to engage a small group of “influencers” and senior change-agents in
a practical and solution-oriented policy discussion. The numbers of non-essential attendees were
limited in order to encourage exchange and trust and keep the discussions focused. Chatham House
rules were followed in all dialogs to encourage frank and open discussion of complex and sometimes
contentious issues.
Following the stakeholder and context analyses, participants were selected and invited from sectors
relevant to the topic and desired outcomes. Priority was placed on attracting relevant high-ranking
officials to bring more “political capital” to the dialog and official invitation letters were signed by the
CHRODIS PLUS Coordinator. An appropriate venue was selected to maximize attendance and the
policy dialog was conducted in the national language. Exceptionally, in particular when it concerned
an external–yet essential–participant setting out the EU background/relevance, an introductory session
was conducted in English.
Policy dialog documents were sent to the confirmed participants at least two weeks prior to
the dialog and included a detailed draft agenda and pre-prepared question list, as well as further
background materials, as appropriate. The pre-prepared questions aimed to: (1) introduce the identified
issue (problem definition), (2) link the broad themes to more specific topics (an overview of current
policy and program responses), (3) and address the key/core issues which would be explored in the
policy dialog in order to elicit tangible and workable actions by the end of the meeting. This meant
the discussion could start from a place of common understanding of the problem (e.g., inequalities in
tobacco use) and move quickly into debate on potential response options.
2.5. Reporting and Action Plan
The policy dialogs were intended to be a single element in a broader policymaking cycle,
either informing the content of new policy or forming a component of policy evaluation and review.
For this reason, it was essential that each national organizer prepare for each dialog in advance by
providing appropriate contextual information and resources, as well as continue after the dialog by
preparing a report with the dialog minutes and an action plan outlining tangible and feasible next
steps to address the identified problem. For each step of the action plan, dialog participants were
assigned roles and suggested timelines were proposed.
A pre-structured reporting template was provided to the national organizers in advance of the
dialog. This template complemented the national organizers and moderators in their preparations for
the dialog. All reporting templates were submitted to the project leaders within one month following
the completion of the dialog. Reports and proposed action items were then reviewed for clarity and
feasibility by CHRODIS PLUS task leaders.
2.6. Evaluation
A common participant feedback questionnaire was designed to be sent to participants at the
end of each policy dialog (Supplementary Questionnaire S3). The aim of the questionnaire was to
assess the satisfaction of participants with the organization and outputs of the meeting, as well as
compiling personal opinions about the main national barriers and facilitators to adopt the measures
and recommendations discussed during the policy dialog. The CHRODIS PLUS evaluation leader
analyzed the questionnaire results and shared a compiled report with project leaders and national
organizers. This report had two main objectives: (1) to receive feedback about the meeting and (2) to
identify aspects that could be improved in future policy dialogs in order to generate the best discussions
and outputs. Finally, the survey was sent to participants in ten of fourteen policy dialogs. The survey
response rates are included in Table 1.
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3. Results
While fourteen national policy dialogs were performed (Supplementary Table S1), three were
selected as case studies for this article on the basis of their selected topics and the high response rate to
the participant feedback questionnaire (as described above).
3.1. Ireland
The Irish policy dialog was held on 12 June 2018 at Europe House in Dublin. The dialog topic was
“Socioeconomic Inequalities in Tobacco Use”. Annually, 5900 people die in Ireland of causes related
to tobacco use (about one in five of all deaths and the largest single cause of preventable death) [30].
Tobacco use drives an excess of acute and chronic ill-health and disability as well as premature death,
particularly in disadvantaged communities [31]. In 2013, the economic cost of tobacco consumption
in Ireland was estimated at €1.5 billion [32]. Tobacco use contributes to the generation, maintenance
and deepening of poverty and diminished social and economic opportunity through both direct and
indirect mechanisms [33].
The objectives of the dialog included the following: (1) identifying and exploring which elements of
the Tobacco-Free Ireland program (established in 2013) were currently targeted to address socioeconomic
inequalities in tobacco use, (2) exploring how European partnerships and initiatives could be leveraged
in the future to support the reduction of inequalities in tobacco use in Ireland and (3) identifying which
policy and program actions should be sustained and what new actions should be considered to address
inequalities in tobacco use in the future.
The dialog brought together participants from the Tobacco and Alcohol Control Unit—Department
of Health; Health Service Executive; Irish Cancer Society; Institute of Public Health in Ireland; and the
Department of Public Expenditure and Reform (the department responsible for the development of
efficient public spending, including equality budgeting). The following conclusions were reached
by dialog participants: (1) approaches to addressing inequalities in tobacco use must be effective in
targeting and addressing both prevention and smoking cessation; (2) tobacco pricing is central to
addressing inequalities in smoking—but not enough on its own; (3) tobacco and social disadvantage is
a cross-government agenda and integration in the operation of statutory services may be beneficial;
(4) changing attitudes and norms around tobacco in disadvantaged communities is important, but can be
challenging; (5) knowledge on what works for disadvantaged groups is evolving, but incomplete—this
creates difficulties in decisions on investment of resources; (6) partnerships are critical to success
in the health inequalities component of tobacco control policies and programs; (7) monitoring and
accountability on health inequality dimensions is important; and lastly that (8) effective advocacy is
critical to make progress on inequalities—but some of those most vulnerable to tobacco related harm
are underrepresented.
Based on the conclusions reached, the Irish policy dialog action plan detailed policy options for
the following four action points for further collaboration:
(1) Build tobacco into government considerations for equality budgeting. The Department of Public
Expenditure and Reform agreed to link with the Department of Health to consider the equity
impact of fiscal policy on tobacco. Equality budgeting involves providing greater information
on the likely impact of budgetary measures across a range of areas such as income, health and
education and how outcomes differ across gender, age, ethnicity, etc. Equality budgeting helps
policymakers to better anticipate potential impacts in the budgetary process, thereby enhancing
the government’s decision-making framework. Coupled with Ireland’s commitment to keeping
tobacco control policy free of any influence from the tobacco industry (in line with the WHO
Framework Convention for Tobacco Control), equality budgeting can help highlight the societal
returns from investing in equity-focused tobacco control legislation and policy.
(2) Build a more defined health inequality dimension into the development of clinical smoking cessation
guidelines based on best evidence. At the time of the policy dialog, the Health Service Executive
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was leading a process to develop updated Clinical Practice Guidelines on the management of
tobacco addiction. This process included an objective and comprehensive review of international
evidence as well as a consideration of the national context for service delivery. Subsequent to the
policy dialog, a presentation on evidence relating to health inequalities and the conclusions of the
policy dialog were presented directly to the clinical practice guideline development group.
(3) Enhance efforts to target investment in tobacco control including resourcing for equity-focused smoking
cessation and progressive tobacco taxation. All partners agreed on the importance of seeking
opportunities to access additional resources to advance equity-focused smoking cessation, as there
are ongoing challenges with securing sufficient resources in this field. Participants acknowledged
that health promotion and public health/prevention budgets are constrained and there are
competing priorities and that advocacy groups are critical to influencing at political level to
ensure that tobacco control is understood and prioritized. Since the policy dialog, the Health
Service Executive has enhanced their work on health equity in smoking cessation, while tobacco
taxation in Ireland has continued to rise.
(4) Greater engagement with disadvantaged groups, in particular with people with mental health difficulties.
Participants agreed that there is a need to better understand the lived experience of socially
disadvantaged people in their journey in and of tobacco addiction. Co-design with service users
can be critical to engaging disenfranchised people and communities with state run smoking
cessation supports. The findings of a comprehensive research project on this issue were discussed
by the Clinical Practice Guidelines Development Group on smoking cessation. An engagement
exercise (a conversation café event) with service users was also developed and held with mental
health service users following the policy dialog [34].
The evaluation of the dialog found that the background information shared with participants,
organization and facilitation of the dialog were rated as “excellent” by 75% of respondents. Other positive
aspects participants cited were the inclusion of a member of the Department of Public Expenditure
and Reform and the diversification of smoking cessation strategies in order to reach vulnerable groups.
The perceived main barriers for the national implementation of the outcomes/proposals agreed in the
policy dialogs were a lack of resources (specialist, supporting structures) and budget/funding issues.
Further conclusions from the Irish policy dialog can be found in Table 2.
Table 2. Summary of the main conclusions of the national policy dialogs in Ireland, Portugal and Spain.
Country Ireland Portugal Spain





• Diversification of smoking
cessation strategies in order
to reach vulnerable groups.




• Continued attention to
accessibility and affordability
of tobacco including taxation.
• Integrating tobacco control
as a poverty prevention and
response measure
across government.





• Need for a formal legal
framework on publicity for
children, regulating the
(digital) marketing of foods
and beverages.
• Awareness that
self-regulation is not enough;










• Health and equity in
all policies.
• The firm commitment of
the Ministry of Health
and the Ministry of
Environment to
work together.
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Table 2. Cont.
Country Ireland Portugal Spain
Main barriers
• Lack of resources: specialist,
supporting structures, etc.
• Budget/funding issues.
• Difficult to reach
vulnerable groups.
• Competing pressures.




• Power of the food industry.
• Existence of lobbies.
• Delay of the
legislative process.
• New challenges of digital
media as attract children and
young people through
different activities.










contribution to their own




• Evaluation milestones within
policy delivery.
• Involvement of multiple
government departments
and sectors.






• Common understanding of
the situation, needs and
problem to solve among
different stakeholders,
including public authorities.
• Sharing the principles and
objectives of action.
• Institutional commitment.
• New political leadership
at both Ministries (Health
and
Ecological Transition)
• Formal and robust











Strong points of the
PD (according to
participants)
• Inclusion of a member of the
Department of Public
Expenditure and Reform.
• Discussion on prices and
taxation as tobacco
control measures.
• Generated a will for
continuing working on the
topic together and in other
scenarios/events.
• Very good and useful
conclusions about what
needs to be done and what






• Fulfilment of the prior
objective of the policy dialog:
the approval of the law that
restricts the marketing and
publicity of inadequate foods





the Ministry of Health,
Consumer Affairs and
Social Welfare and the
Ministry for the
Ecological Transition.
• Implication of key
policy makers.
Weak points of the
PD (according to
participants)
• More stakeholders required
especially patients
and public.
• It could be improved by
including service users




• Lack of some background
and information about the JA
CHRODIS PLUS.
• Expected more active
participation from
all audience.
• Expected more specific
actions agreed.
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3.2. Portugal
The Portuguese policy dialog was held on 30 January 2019 at the offices of the Directorate-General
of Health in Lisbon. The topic was “Advertisement of Food and Beverages to Children”. In Portugal,
86% of the burden of disease is due to chronic diseases and 15.8% of the years of healthy life lost are due
to inappropriate eating habits. Thus, 41% of the total years of healthy life lost due to premature death
could be avoided if we eliminated the major modifiable risk factors, such as overweight, sedentary
lifestyle and poor eating habits, tobacco and alcohol use [35]. Portugal has been tackling childhood
obesity in many different ways over the past years. The WHO COSI (Childhood Obesity Surveillance
Initiative) study has shown a decrease in childhood overweight and obesity by almost 8% between 2008
and 2019, but more can be done. As of 2019, one-third of Portuguese children remained overweight
or obese, a problem associated with inadequate eating habits: 69% of children do not consume the
WHO-recommended 400 g of fruit and vegetables and 43% consume more than one soft drink on a
daily basis [36].
Food advertising to children promotes products that are typically high in sugars and fat.
The evidence indicates that unhealthy food and beverage marketing increases dietary intake and
preference for energy-dense, low-nutrition foods and beverages [37]. The data supports public health
policy action that seeks to reduce children’s exposure to unhealthy food advertising [38]. Food literacy,
beginning early in life, is key to lowering the percentage of overweight people in Portugal and,
consequently, decreasing the prevalence of chronic diseases among the adult population. Several WHO
strategic documents recommend that Member States implement measures to reduce the impact of
non-food and beverage marketing and advertising, namely the WHO European Food and Nutrition
Action Plan 2015–2020 [39], the Vienna Declaration on Nutrition and Noncommunicable Diseases
in the Context of Health 2020 [40] and the Report of the WHO Commission on Ending Childhood
Obesity [41].
Against this backdrop, the main objective of the Portuguese policy dialog was to gather a group
of national stakeholders together in order to find ways to tackle the issue of advertisement of food
and beverages to children at national level. The specific objectives included: (1) understanding the
perception of each participating entity regarding the current status of the matter, (2) understanding
what each participating entity has done to date to address the matter, (3) discussing the effectiveness
of regulation versus self-regulation, (4) discussing main barriers to regulation of food and beverage
advertisements to children, and finally (5) understanding how each participating entity could contribute
to next steps to tackle the issue. Participants in the dialog came from: the Directorate-General for
Health; the Directorate-General for Consumer Affairs; the People–Animals–Nature Political Party;
the Ministry of Agriculture; the Portuguese Regulatory Authority for the Media; the Directorate-General
for Education; the Portuguese Association for Consumer Protection; the Food Safety and Economic
Authority; and the Portuguese Institute for the Ocean and Atmosphere.
The following conclusions were drawn by the end of the dialogue: (1) all entities present in this
policy dialog were directly or indirectly working on issues related to this subject; (2) in general, all
entities agreed with self-regulation, but considered that it should coexist with regulation; (3) the role of
health literacy is important in changing behavior among children, young people and families; (4) digital
media creates new challenges and barriers for the regulation of advertised content; (5) the measures to
be applied must focus not only on the media and digital platforms, but also on activities/actions that
attract children and young people, such as festivals, merchandising and sporting events, among others;
(6) the age of 18 years was selected as a cutoff for the target population (though eventually the cutoff
was changed to 16 years old); (7) it was agreed that digital influencers should be used as partners for
promoting healthier food choices; and that (8) “counter advertising” methods were also seen as very
important to demystify traditional advertising practices.
The action plan detailed two action points, both oriented towards the creation of working groups:
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(1) A working group focused on finalizing a legislative proposal regarding advertisement of food and beverages
to children. This proposed legislation aimed to limit advertising of foods and beverages with a
high content of sugar, fat or sodium in preschool, basic and secondary education establishments,
in children’s playgrounds and within a specific radius of those places, as well as in publications,
programs or activities for minors. It also aimed to prohibit advertisement of such foods in the
time before and after television programs which have a certain percentage of the audience below
18 years of age. The members of this working group met regularly to monitor and advocate for
progress towards completion of this regulation. The legislation was successfully passed into law
on 23 April 2019 with additional regulations approved on 21 August 2019 [42]. This working
group has therefore completed its tasks.
(2) A working group focused on the promotion of health and food literacy among the Portuguese population
(the “National Health Literacy Commission”). The objectives of the group were to define health and
food literacy actions with two aims: (1) to improve the health and food literacy of the population
and (2) to work together with digital influencers in order to raise awareness about health and
food literacy. The working group was created, but its tasks have been put on hold due to the
COVID-19 pandemic. Over time—and with the help and contribution of the National Program for
the Promotion of Healthy Eating—further focus will be made on promoting healthy eating habits
among the Portuguese population. For example, the Directorate-General for Health of Portugal
(DGS) is currently undergoing a study among Portuguese families to verify in which level the
legislation is really being respected by the industry and by all the different communication
channels. DGS will implement a pilot study based on “CLICK: The WHO Europe framework to
monitor the digital marketing of unhealthy foods to children and adolescents” [43].
The participant feedback questionnaire results found that the organization and the technical
conditions of the meeting were excellent, receiving an average rating of 9.1 of 10. The participant
stakeholders very positively expressed their will for continuing working on the topic together and in
other scenarios/events. Further conclusions from the Portuguese policy dialog can be found in Table 2.
3.3. Spain
The Spanish policy dialog was held 10 June 2019 at the offices of the Ministry of Health, Consumer
Affairs and Social Welfare in Madrid. The topic was “ALTERNATIV35: Health Impact Assessment.
Alternatives for an effective implementation of Article 35 of the Spanish Public Health Act 33/2011” [44].
The topic was selected because of the need to further develop the Article 35 of the Spanish Public
Health Act, which obliges Spanish Public Administrations to perform Health Impact Assessments
(HIA). The Dialog took place between the Ministry of Health, Consumer Affairs and Social Welfare
(MoH) and the Ministry for Ecological Transition (MET).
The main objectives were to reinforce collaboration between the MoH and the MET to jointly
address health and environment issues and to assess the possibility to include health impact assessment
in environmental projects and measures. They specifically hoped to achieve a clear commitment to
intersectoral work addressing equity and social and environmental determinants of health, as well as
the establishment of formal mechanisms for joint work between the two ministries.
The dialog drew participants from: the Directorate of Public Health, Quality and Innovation
(MoH); the Directorate of Biodiversity and Environmental Quality (MET); the Carlos III Health Institute;
the Ministry of Science and Innovation; the Sub-directorate of Health Promotion and Public Health
Surveillance (MoH); the Sub-Directorate of Environmental Health and Occupational Health (MoH);
the General Secretary of Health and Consumer Affairs (MoH); the Sub-Directorate of Environmental
Assessment (MET); the Sub-Directorate of Air Quality and Industrial Environment (MET); and the
Sub-Directorate of Quality and Innovation in Health (MoH).
The discussion evolved around three core points: (1) exploring the views of the participants
toward the links between health and environment and possible synergies, (2) improving the integration
of health in environmental policies and in environmental impact assessments and (3) how participants
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rated the HIA recommendations provided in the background document and preparatory work
conducted prior to this dialog.
Participants positively received the participatory work, and the following priority measures
for the integration of health into environmental policies were agreed: (1) participation of technical
staff from the health departments in consultations on Environmental Impact Assessments (EIA);
(2) defining the areas in which to carry out the HIA; (3) establishment of indicators and criteria for HIA;
(4) technical advances in the establishment of relevant measurements and thresholds for health impact
control; (5) overcoming the limitations for the mobility of technical staff among the Ministries involved;
(6) participation of technical staff from the health departments in the preparatory reports prior to
legislative proposals; (7) establishment of methodological guidelines to perform EIA; (8) reasonable
criteria that prevent public administration to carry their day-to-day activities because of insufficient
evidence; and (9) establishment of procedures to evaluate plans and programs that are not currently
evaluated through EIA.
The action plan detailed just one action point: an agreement to create an interdepartmental
working group between the two Ministries to address the above-mentioned priority measures. This is
a permanent working group with participants from both Ministries (Ministry of Health, Consumer
Affairs and Social Welfare and Ministry for Ecological Transition).
The evaluation of the dialog found that participants highlighted the importance of the topic and
valued very positively the communications, interaction and collaboration between the Ministry of
Health, Consumer Affairs and Social Welfare and the Ministry for the Ecological Transition. Further
conclusions from the Spanish policy dialog can be found in Table 2.
4. Discussion
On the basis of the results of the national policy dialogues—and in particular the three selected case
studies—several important themes emerged. These relate to affirming the value of policy dialogues
as a deliberative dialogue approach for health policymaking. Specific uses of the policy dialogue
as a tool for enhancing policymaking are also discussed. These include the value of using policy
dialogues as a tool to bring together key stakeholders, to support a Health in All Policies (HiAP)
approach and to improve the transparency of policymaking processes. In addition, we found that the
policy dialogs were a particularly relevant activity in the context of a joint action, which both aims
to build individual Member State capacities in the selected area (e.g., prevention and management
of chronic disease), while also demonstrating and enhancing EU added value from the collaboration.
Finally, common strengths and weaknesses of the particular CHRODIS PLUS methodology—in the
context of JA CHRODIS PLUS—are discussed.
4.1. Policy Dialogs as a Tool to Support Coalition Building, Address Complexity and Adopt a Health in All
Policies Approach
Chronic diseases are the result of a combination of genetic, physiological, environmental and
behavioral factors [45]. The complexity of chronic disease prevention and management presents
a “wicked” problem, one that can only be resolved by navigating potential conflicts of
goals/interests/stakes and important technical disputes, as well as engaging multiple actors from several
levels of government [12]. Resolving such problems requires policy leadership and commitment
and cross-sectoral engagement across such domains as health, fiscal, social, employment and the
environment. Broader coalitions of stakeholders reduce the fragmentation and “silo” mentality
that has often hampered intersectoral solutions [15]. Yet, there is a broad lack of good practices in
evidence-informed policymaking for complex challenges such as prevention and treatment of chronic
diseases [46,47].
In the past decade, it has become clearer that policymaking processes should espouse more
deliberative approaches, reconfiguring the traditional models of policy development built around
interests, institutions and existing policies [19]. The literature on coalitions points towards the need for
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careful discussion, deliberation and debate around goals, targets and issues, an open and inclusive
process, a recognition of varying levels of contribution and capacity and transparent reporting and
recording [20,21]. Tools that seek to think with complexity promote a better understanding of the
wider political, institutional and cultural contexts in which health outcomes, risk factors and behaviors
are embedded [19,48]. The findings of our research with policy dialogs for health promotion supports
the work of Ayana and colleagues, whereby, the policy dialogs are a space in which non-state actors
can document and effectively communicate field evidence, form strong networks with state actors and
establish alliances with key decision-makers [13].
As Table 2 demonstrates, a key strength across the three case studies was the ability of the policy
dialogs to facilitate interactions between different sectors—notably between health, finance and
environment. The dialogs set the groundwork for future joint activities (e.g., the action plan,
working groups). Yet, participant feedback from each case study also indicated that there was a
perceived need to engage still more stakeholders, particularly from the target populations who would
primarily be affected by the proposed policies. Facilitating more interactions between policy makers,
influencers and target populations can help identify the intervention points and the relative contribution
of different stakeholders and pursuing a systems approach encourages action at the most crucial
points in the system [46]. Adopting a complex systems approach means navigating away from simple
and linear causal models towards thinking how processes and outcomes within a system facilitate
change [21].
HiAP and addressing complexity require a new suite of tools compared to those traditionally
used in the development of policy. They also entail more focus on implementation and solid evaluation
processes at short-, mid- and long-term [45]. We have found that the use of policy dialogs can encourage
new alliances, connections and deepen working relationships between sectors. We have found that
policy dialogs can provide a new way to empower thinking away from isolated intervention approaches
and reconfigure governance by breaking departmental silos and facilitating cooperation and a sense of
shared purpose with broader groups of stakeholders. Our findings complement research conducted by
Ongolo-Zog et al. as dialog participants engaged with new information and moved to decision points
following the dialogs [14] and new policy issue networks emerged in Ireland, Portugal and Spain as a
result of the dialogs.
4.2. Policy Dialogs as a Tool for Enabling National Policy Development through European
Cross-Country Collaboration
Rising levels of chronic disease are a significant challenge for all European Member States,
but Member States vary considerably in their policy responses [49]. These different responses were
reflected in the wide range of topics and diverse types of stakeholders involved in the CHRODIS PLUS
national policy dialogs. At the same time, however, preparing for the national policy dialogs provided
national organizers with an opportunity to exchange and learn from other countries as well as reflect
on the European common frameworks and any precedents from across Europe that may support their
efforts. In the case of the three selected case studies, each built on existing policy efforts inspired
by broader European or EU Member State policy developments. For instance, Tobacco-Free Ireland
built on the WHO Framework Convention for Tobacco Control and a number of EU Directives and
Recommendations [50]. National initiatives to regulate advertising to children had been undertaken in
countries such as Denmark, France, Spain and the United Kingdom before the Portuguese regulation
was drafted [51]. In preparations for the Spanish policy dialog, a review of proposals for health
equity assessment, including from Spanish autonomous communities as well as the joint action
“Equity Action” was conducted [52].
Thus, national policy dialog topics were often influenced by wider trends and policies happening
in the EU. The overlap seen in selected topics across policy dialogs (Supplementary Table S1) suggests
that CHRODIS PLUS activities could directly help Member States to address similar concerns and to
learn from one another’s experiences to contribute to more successful implementation of new policies
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or policy revisions. National organizers in the three case study countries found that this connection
with the wider “European” identity—as part of an EU co-funded joint action—brought more value and
credibility to the policy dialog process. Having project leaders from CHRODIS PLUS participate in each
dialog, and, in the case of Ireland, hosting the dialog in Europe House, also underscored the potential
contributions that each policy dialog’s outcomes could have in influencing other decision-makers
across Europe. The dialogs therefore proceeded in line with the specific goal CHRODIS PLUS to
support Member States to use cross-national initiatives to reduce the burden of chronic disease while
assuring health system sustainability and responsiveness [6]. The CHRODIS PLUS policy dialogs
offered a mechanism for knowledge translation and exchange within and between EU Member States,
particularly around decision-making in health systems [19].
4.3. Policy Dialogs as a Method for Enhancing Transparency and Standardization of Policymaking Processes
We argue that policy dialogs can contribute to bridging the gap between policy and operational
delivery. The CHRODIS PLUS policy dialog methodology relies on thorough stakeholder and context
analyses prior to the dialog, allowing participants to review the latest evidence and come to table
with a common understanding of the topic at-hand. This can facilitate more evidence-based and
transparent decision-making procedures, with the potential to reduce the “black box” of traditional
policymaking [23]. Our experience of using the CHRODIS PLUS policy dialog format shows that
it could be adapted for use in different contexts and at different stages of the policymaking process.
It could be used not only to examine and refine existing policies, but also to “kickstart” discussions
around emerging areas of policymaking. They could also be used not only to translate high-level
policy goals into national legislation, but also to initiate new programs, services and community
engagement. Our analysis of the participant feedback and action plans from the national policy dialogs,
including the three case studies, identified the following “success factors” for CHRODIS PLUS national
policy dialogs:
• Careful and “fit-for-purpose” stakeholder engagement prior to, during and after the dialog event;
• Close liaison between national dialog leads and the CHRODIS PLUS task leaders;
• Preparation and planning on supporting documentation including questionnaires, briefing
documents, reporting and evaluation;
• Careful structuring and facilitation of dialog discussions, including the follow of the Chatham
House Rules;
• Agreement and common writing of conclusions by participants;
The engagement of key stakeholders seemed to have a crucial role in the planning and
implementation of new approaches [20]. Policy dialogues were useful in the context of implementation
science and in bridging the gap between policy and strategy level goals and actions and the “real
world” challenges of operationalizing those goals and actions. Stakeholders were not only limited to
those directly involved during planning, but also to those that have a primary and secondary role when
implementing the practice, particularly for ensuring its sustainability over time. Finance, marketing or
environmental departments are examples of stakeholders whose participation in the policy dialogs
was highly valued by attendees. These stakeholders seemed to create further awareness of potential
barriers to implementation related to access to resources, reaching vulnerable groups, ethical concerns
and potential competitors to new approaches, sometimes not fully known by the developers and
implementers of new health strategies. The policy dialog also highlighted where evidence to guide
investment in policy and practice was lacking or where there were gaps in knowledge translation in the
research community. The creation of new synergies between those stakeholders, as well as establishing
stable communications and coordination (e.g., working groups) between them seemed to be one of the
most accepted approaches to ensure successful design of policies oriented to contextual needs and
sustainable implementation.
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Further analysis of the participant feedback and action plans also revealed the most relevant
common difficulties highlighted in the policy dialog process (some of these points have been illustrated
in Table 2). Barriers that inhibit the implementation of new practices include: a lack of supportive legal
frameworks and measures, weak or old regulations, poor diversification of strategies and ambiguity on
technical, human, legal and financial resources needed for implementation. Three key approaches were
highlighted during the policy dialogs in order to create greater impact and sustainability on the design
and implementation of new practices: (1) knowledge that self-awareness of target population was not
enough and therefore marketing, communication and diversity of approaches were needed in order to
reach vulnerable groups; (2) necessity of creating stable working groups, “policy partnerships” and
relationships with people from across different departments and policy fields, lobbies and associations
involved in the implementation/operationalization for a continuous sharing of communication and
information; and (3) creation of evaluation strategies of the implementation in order to share transparent
results to policy makers and stakeholders, making timely adjustments when necessary.
5. Conclusions
This section summarizes key learnings from the preparation, organization and implementation of
the CHRODIS PLUS national policy dialogs. We also suggest some recommendations for future action.
• The CHRODIS PLUS policy dialog methodology proved an effective mechanism to provoke
deliberative discussion on a wide range of policy topics in different settings.
The dialogs generated added value by stimulating national thinking and concrete actions, including
post-facto, about priorities and rationales to address chronic diseases. The questionnaire, reporting,
preparation of action plans and evaluation of the feedback from participants helped keep stakeholders
engaged, raise their awareness of needs, challenges and opportunities, as well as set concrete goals
and objectives for a wide variety of subjects in a context of chronic diseases.
The long-term uptake and eventual scale-up of good practices in health promotion and disease
prevention can hardly be achieved without a multilevel and multisectoral approach. Our research
adds further support to usefulness of an inter-sectoral approach to health promotion and disease
prevention as key to addressing chronic diseases. Given that many of the determinants of chronic
disease lay outside of the health sector (e.g., environment, education, socioeconomic status), all dialogs
acknowledged the importance of bringing together and engaging stakeholders from outside of the
health sector. We have managed to effectively use a deliberative debate tool such as policy dialogs to
increase stakeholders’ engagement. Most action plans laid out specific activities or areas of further
work that would bring in other stakeholders in future actions.
Using a framework like the CHRODIS PLUS policy dialog methodology can support future
policy makers in such activities as identifying key stakeholders, preparing background documentation,
selecting the optimal points in the policymaking process for deliberative dialog and implementing and
evaluating policy dialogs.
• Ensuring adequate human and financial resources to accomplish objectives set out during the
policy dialogs– and working to gain and maintain political commitment—are essential.
An important structural challenge to the CHRODIS PLUS policy dialog process related to a lack
of resources allocated for follow-up activities and insufficient monitoring (e.g., mid- and long-term
evaluation) of the implementation of national action plans. This lack of follow-up meetings and
processes falling outside of the scope/timeframe of the joint action makes it challenging to ensure
continuity of any processes initiated during the policy dialogs. However, two of the three selected case
studies have already managed to continue work beyond the fixed temporary framework of their action
plans. We conclude that the sustainability can be improved if all conceived actions are integrated into
existing policies, programs or processes. In addition, political capital and commitment—and particular,
sustained funding—were seen as key to achieving many of the follow-up actions indicated by the
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policy dialogs [24]. We suggest that further research of this aspect could result in important longer-term
learnings about policy dialog planning, implementation and overall impact. Understanding how
priorities and political landscapes adapt over time, it is also important that dialog participants envision
ways to gain and maintain political commitments from the necessary policy- and decision-makers.
Future projects and programs, including joint actions, which rely on policy dialogs could use these
learnings to inform the design and funding of their policy dialog processes. Overall, more research
on effective policy dialog design, informed by the latest literature on deliberative dialogs, could help
standardize policymaking procedures and improve network governance through increased dialog and
civic engagement [20,22,27].
• Priority-setting and implementation across sectors can improve the resilience of health systems
and opportunities for investment in Health in All Policies, both at EU and Member State levels.
Given that many of the determinants of chronic disease lay outside the health sector
(e.g., environment, education, socioeconomic status), an effective policy response to prevent and
manage chronic diseases must improve communication and coordination across all sectors and all
levels. Working together to establish a common understanding of challenges and to jointly set mutually
beneficial priorities can reduce the burden on the health system, enhance efficiency of social service
provision and increase opportunities to fund new and innovative approaches [53]. While investments in
health and wellbeing are first and foremost a government responsibility, many European programs also
invest in health (including indirectly through other social sectors). Unfortunately, this information is
dispersed across many ministries (e.g., health, education, finance, justice, environment). The CHRODIS
PLUS policy dialogs showed a need for facilitated inter-ministerial and vertical communication on
opportunities for improving health policy and practice within the EU and its Member States.
Improving awareness of actions which can be taken at national level (e.g., joint health and
environmental assessments, equality budgeting techniques) can increase the impact and perceived
ownership of health policies among key stakeholders. Improving awareness of EU funding opportunities,
such as joint actions, can also enhance the value of these programs across all levels of governance.
We recommend strengthening the EU’s national focal points (for health) and improving their cooperation
across sectors (e.g., bundling of projects). We also suggest that the European Commission’s Steering
Group on Health Promotion, Disease Prevention and Management of Noncommunicable Diseases could
be better leveraged to facilitate inter-ministerial and vertical communication to enhance HiAP approaches
at national and European levels [54].
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